Silexion Therapeutics Corp Director Resigns Effective Aug 1, 2026

What Happened
Silexion Therapeutics Corp (SLXN) filed an 8-K on July 31, 2026, announcing that Professor Amnon Peled notified the Board of his resignation on July 30, 2026. His resignation is effective August 1, 2026, and was given for personal reasons. The filing states the resignation did not result from any disagreement with the Company regarding its operations, policies, or practices.

Key Details

• Director: Professor Amnon Peled.
• Notice given: July 30, 2026; Effective date: August 1, 2026.
• Reason: Personal reasons; explicitly not due to any disagreement with the Company.
• Reported in Form 8-K under Item 5.02 (departure of directors).

Why It Matters
A board member departure can affect board composition, committee membership, and governance voting. Because the filing confirms no disagreement with management or company policies, this appears to be a personal departure rather than a governance dispute. Investors should watch for any subsequent filings announcing a replacement director or changes to board committees, which could be material to governance and oversight.